name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
4MDD_B_D_300_1.pdb,4MDD,,2.40,P04150,PF00104,1.10.565.10,B,220,D,12,GLEDIIRKALMG,CHHHHHHHHHHC,413210230034,300,1,1,CCCCCCCCCCCC,12,0,F:0;G:0;I:0;K:0;L:0;M:0;Q:0;V:0;W:0,F:0;G:0;I:0;K:0;L:0;M:0;Q:0;V:0;W:0,A:3;D:4;E:5;F:1;G:1;I:1;K:9;L:3;M:2;N:2;P:4;Q:4;R:5;S:4;T:3;V:2;Y:4,A:10;C:4;D:6;E:6;F:6;G:6;H:5;I:8;K:2;L:29;M:8;N:7;P:2;Q:7;R:5;S:14;T:8;V:7;W:3;Y:8,H:0;T:0,H:0;T:0,C:14;E:1;G:2;H:30;T:10,C:16;E:12;G:1;H:110;T:12,300_1,F:1;G:1;I:1;K:1;L:2;M:1;Q:2;V:2;W:1,H:11;T:1,F:0;G:0;I:0;K:0;L:0;M:0;Q:0;V:0;W:0,H:0;T:0,888766666679,GLN_62_B_COREBINDING;GLN_67_B_COREBINDING;GLY_38_B_COREBINDING;ILE_42_B_COREBINDING;LEU_59_B_COREBINDING;LEU_66_B_COREBINDING;LYS_49_B_COREBINDING;MET_63_B_COREBINDING;PHE_54_B_COREBINDING;TRP_70_B_COREBINDING;VAL_41_B_COREBINDING;VAL_45_B_COREBINDING,NLGLEDIIRKALMGS,-1,-1,,999999999999,GLY_1_D_C;LEU_2_D_C;GLU_3_D_C;ASP_4_D_C;ILE_5_D_C;ILE_6_D_C;ARG_7_D_C;LYS_8_D_C;ALA_9_D_C;LEU_10_D_C;MET_11_D_C;GLY_12_D_C,"CRYSTAL STRUCTURE OF THE GLUCOCORTICOID RECEPTOR BOUND TO A NON 2 STEROIDAL ANTAGONIST REVEALS REPOSITIONING AND PARTIAL DISORDERING OF 3 ACTIVATION FUNCTION HELIX 12"
